文献速递系统性红斑狼疮

SLEAR基因多态性rs13259960与系统性红斑狼疮易感性相关

Association of the Polymorphism rs13259960 in SLEAR With Predisposition to Systemic Lupus Erythematosus.
PubMed 文献 · Arthritis Rheumatol · 2020-04-26

在中国汉族人群(4,556例SLE患者和9,451名健康对照)中进行lncRNA基因位点全基因组调查,鉴定出lncRNA基因SLEAR上的新SLE易感位点rs13259960(OR 1.35,Pcombined=1.03×10-11)。该位点A>G变异位于内含子增强子,损害STAT1募集,导致SLE患者PBMC中SLEAR表达降低(P=0.0241),SLEAR通过结合RNA结合蛋白形成复合物激活下游抗凋亡基因,其表达与SLE患者外周血细胞死亡程度相关(r=0.824,P=2.15×10-8,n=30)。

要点

  • rs13259960位于lncRNA基因SLEAR,与SLE易感显著相关(OR 1.35)。
  • 风险等位基因G损害STAT1增强子募集,降低SLE患者PBMC中SLEAR表达。
  • SLEAR通过RNA结合蛋白复合物激活抗凋亡基因,调控细胞凋亡。

核心结论

  • rs13259960风险变异通过调节SLEAR表达赋予SLE易感性,为SLE病因学提供见解。

研究设计与样本

  • 在中国汉族受试者(4,556例SLE患者和9,451名健康对照)中进行lncRNA基因位点全基因组SLE风险变异调查。
  • 采用生化与分子细胞生物学分析探索SLEAR风险变异的功能相关性,并使用体外功能丧失和功能获得策略。
  • 评估SLEAR与SLE患者外周血凋亡程度的相关性。

主要发现

  • 鉴定出lncRNA基因SLEAR上的新SLE易感位点rs13259960(OR 1.35,Pcombined=1.03×10-11)。
  • rs13259960的A>G变异位于内含子增强子,损害STAT1募集至与SLEAR启动子成环的增强子,导致SLE患者PBMC中SLEAR产生减少(3例G/G、22例A/G、103例A/A;P=0.0241)。
  • SLEAR与RNA结合蛋白ILF2、hnRNP F和TAF15相互作用形成复合物,激活下游抗凋亡基因转录。
  • SLEAR在体外调节Jurkat细胞凋亡,其表达水平与SLE患者外周血细胞死亡程度相关(r=0.824,P=2.15×10-8;n=30)。

临床怎么用

  • rs13259960基因型可能作为SLE易感性评估的遗传标记,但需进一步验证。
  • SLEAR表达水平与凋亡程度相关,提示其可能作为疾病活动性或凋亡相关病理的潜在生物标志物。

局限性

  • 研究主要基于中国汉族人群,结果外推至其他种族需谨慎。
  • 功能实验主要在体外细胞系中进行,体内验证尚不充分。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Genome-wide association studies have identified many susceptibility loci for systemic lupus erythematosus (SLE). However, most of these loci are located in noncoding regions of the genome. Long noncoding RNAs (lncRNAs) are pervasively expressed and have been reported to be involved in various diseases. This study aimed to explore the genetic significance of lncRNAs in SLE. METHODS: A genome-wide survey of SLE risk variants in lncRNA gene loci was performed in Han Chinese subjects (4,556 with SLE and 9,451 healthy controls). The functional relevance of an SLE risk variant in one of the lncRNA genes was explored using biochemical and molecular cell biology analyses. In vitro loss-of-function and gain-of-function strategies were used to clarify the functional and phenotypic relevance of this SLE susceptibility lncRNA. Moreover, correlation of this lncRNA with the degree of apoptosis in the peripheral blood of SLE patients was evaluated. RESULTS: A novel SLE susceptibility locus in a lncRNA gene, designated SLEAR (for SLE-associated RNA), was identified at the single-nucleotide polymorphism rs13259960 (odds ratio 1.35, Pcombined = 1.03 × 10-11 ). The A>G variation at rs13259960, located in an intronic enhancer, was found to impair STAT1 recruitment to the enhancer that loops to the SLEAR promoter, resulting in decreased SLEAR production in peripheral blood mononuclear cells from patients with SLE (3 with the G/G genotype, 22 with A/G, and 103 with A/A at rs13259960; P = 0.0241). Moreover, SLEAR interacted with the RNA binding proteins interleukin enhancer binding factor 2, heterogeneous nuclear RNP F, and TATA-binding protein-associated factor 15, to form a complex for transcriptional activation of the downstream antiapoptotic genes. In addition, SLEAR regulated apoptosis of Jurkat cells in vitro, and its expression level was correlated with the degree of cell death in the peripheral blood of patients with SLE (r = 0.824, P = 2.15 × 10-8 ; n = 30). CONCLUSION: These findings suggest a mechanism by which the risk variant at rs13259960 modulates SLEAR expression and confers a predisposition to SLE. Taken together, these results may give insights into the etiology of SLE.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Fan Z, Chen X, Liu L, et al. Association of the Polymorphism rs13259960 in SLEAR With Predisposition to Systemic Lupus Erythematosus. Arthritis Rheumatol. 2020. PMID: 31930717. doi:10.1002/art.41200

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。